World's Best Scientists 2026 revealed!
Francesco Passamonti

Francesco Passamonti

D-Index & Metrics

Medicine

D-Index
98
Citations
45782
World Ranking
8794
National Ranking
299

Overview

Francesco Passamonti is affiliated with the University of Milan in Italy and has contributed extensively to the field of medicine, with a focus on hematology and oncology. Their research primarily centers on myeloproliferative neoplasms and related hematological conditions.

They have authored and co-authored several significant papers, including:

  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, Blood
  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study, 2020, The Lancet Haematology
  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA), 2021, Journal of Hematology & Oncology
  • Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes, 2021, Journal of Clinical Oncology
  • Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study, 2023, The Lancet

Frequent co-authors in their research include:

  • Alessandro M. Vannucchi
  • Claire Harrison
  • Jean-Jacques Kiladjian
  • Barbara Mora
  • Ruben A. Mesa

Their publications are often featured in specialized venues such as:

  • Blood
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances
  • Hematological Oncology

Passamonti's work covers multiple subfields of study within medicine, including:

  • Genetics
  • Hematology
  • Oncology
  • Molecular Biology
  • Infectious Diseases

The main topics of their research encompass:

  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Myeloid Leukemia Treatments
  • Acute Myeloid Leukemia Research
  • Kruppel-like factors research
  • Chronic Lymphocytic Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Hemoglobinopathies and Related Disorders

Best Publications

  • A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders

    Robert Kralovics;Francesco Passamonti;Andreas S. Buser;Soon Siong Teo

  • New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.

    Francisco Cervantes;Brigitte Dupriez;Arturo Pereira;Francesco Passamonti

  • DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status

    Naseema Gangat;Domenica Caramazza;Rakhee Vaidya;Geeta George

  • Prognostic Factors and Life Expectancy in Myelodysplastic Syndromes Classified According to WHO Criteria: A Basis for Clinical Decision Making

    Luca Malcovati;Matteo Giovanni Della Porta;Cristiana Pascutto;Rosangela Invernizzi

  • Philadelphia-Negative Classical Myeloproliferative Neoplasms: Critical Concepts and Management Recommendations From European LeukemiaNet

    Tiziano Barbui;Giovanni Barosi;Gunnar Birgegard;Francisco Cervantes

  • Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

    Alessandro M. Vannucchi;Jean Jacques Kiladjian;Martin Griesshammer;Tamas Masszi

  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

    Francesco Passamonti;Francisco Cervantes;Alessandro Maria Vannucchi;Enrica Morra

  • Survival and prognosis among 1545 patients with contemporary polycythemia vera: An international study

    A Tefferi;E Rumi;G Finazzi;H Gisslinger

  • Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis)

    Tiziano Barbui;Guido Finazzi;Alessandra Carobbio;Juergen Thiele

  • CALR vs JAK2 vs MPL -mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

    A Tefferi;T L Lasho;C M Finke;R A Knudson

  • Life expectancy and prognostic factors for survival in patients with polycythemia vera and essential thrombocythemia

    Francesco Passamonti;Elisa Rumi;Ester Pungolino;Lucia Malabarba

  • Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study

    Tiziano Barbui;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

    Francesco Passamonti;Chiara Cattaneo;Luca Arcaini;Riccardo Bruna

  • Philadelphia chromosome-negative classical myeloproliferative neoplasms: Revised management recommendations from European LeukemiaNet

    Tiziano Barbui;Ayalew Tefferi;Alessandro M. Vannucchi;Francesco Passamonti

  • MIPSS70: Mutation-Enhanced International Prognostic Score System for Transplantation-Age Patients With Primary Myelofibrosis.

    Paola Guglielmelli;Terra L. Lasho;Giada Rotunno;Mythri Mudireddy

  • Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.

    Alessandra Carobbio;Juergen Thiele;Francesco Passamonti;Elisa Rumi

  • Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNs

    Robyn M. Emanuel;Amylou C. Dueck;Holly L. Geyer;Jean Jacques Kiladjian

  • Safety and Efficacy of Fedratinib in Patients With Primary or Secondary Myelofibrosis: A Randomized Clinical Trial.

    Animesh Pardanani;Claire Harrison;Jorge E. Cortes;Francisco Cervantes

  • Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis

    Francisco Cervantes;Alessandro M. Vannucchi;Jean Jacques Kiladjian;Haifa Kathrin Al-Ali

  • Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

    G. Barosi;R. A. Mesa;J. Thiele;F. Cervantes

Frequent Co-Authors

Alessandro M. Vannucchi
Alessandro M. Vannucchi University of Florence
Mario Cazzola
Mario Cazzola University of Pavia
Tiziano Barbui
Tiziano Barbui FROM-Fondazione per la Ricerca Ospedale di Bergamo
Claire N. Harrison
Claire N. Harrison Guy's and St Thomas' NHS Foundation Trust
Francisco Cervantes
Francisco Cervantes University of Barcelona
Ruben A. Mesa
Ruben A. Mesa The University of Texas Health Science Center at San Antonio
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Daniela Pietra
Daniela Pietra University of Pavia
Ayalew Tefferi
Ayalew Tefferi Mayo Clinic
Srdan Verstovsek
Srdan Verstovsek The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you are considering a career in medicine but want alternate pathways or flexibility, there are a range of online healthcare degrees that offer different routes into the profession. Many students opt for nursing-related programs, which can be a more accessible starting point before advancing to higher medical roles.

For those with a Master of Science in Nursing (MSN) looking to elevate their credentials quickly, fastest msn to dnp program options provide an accelerated track to a Doctor of Nursing Practice. If affordability is your main concern, cheapest dnp programs can help you reach your goals without heavy financial burdens.

Alternatively, for those seeking entry-level positions, lpn online programs offer fast-track training to become a Licensed Practical Nurse—a crucial stepping stone in healthcare. If your interest lies in mental health, online msn pmhnp programs prepare you for specialized and in-demand roles as a Psychiatric Mental Health Nurse Practitioner.

These online pathways offer greater flexibility and can serve as valuable alternatives or stepping stones for anyone aiming for a medical career in the USA.

Best Scientists Citing Francesco Passamonti

Trending Scientists